CVS Caremark has agreed to pay $77.6 million in fines for illegally selling a chemical, common in some cold and cough medicines, that ended up being used to make methamphetamine.
Continue reading CVS to Pay $77…
Global pharmaceutical sales are expected to grow by 5% to 7% in 2011, thanks to robust growth in emerging markets, especially China, as well as new innovative treatments, and despite patent expirations and budget pressures in t…
Wal-Mart Stores (WMT) and Humana (HUM) are teaming up to offer a Medicare prescription drug coverage plan that they say will be the cheapest on the market.
Premiums for the Humana Walmart-Preferred Rx Plan will be $14.80 a month, less than half the average premium for Medicare prescription drug plans this year, the companies said in a statement.
“We know every dollar counts,…
Continue reading Wal-Mart, Humana to Offer Low-Cost Prescription Drug Plan
Wal-Mart, Humana to Offer Low-Cost Prescription Drug Plan originally appeared on DailyFinance on Fri, 01 Oct 2010 09:20:00.
Filed Under: Technology, People, Health Care, Wal-Mart Stores, Taxes, Insurance, Retail
Endo Pharmaceuticals (ENDP) agreed to buy generics company Qualitest Pharmaceuticals for $1.2 billion cash.
Qualitest is the sixth-largest U.S. generics company as measured by prescriptions filled. Qualitest will add about $400 million to Endo’s annual revenue and 40 cents per share in annual adjusted earnings, Endo said in a statement.
“We believe that this transaction will…
Continue reading Endo to Acquire Generics Company Qualitest for $1.2 Billion
Endo to Acquire Generics Company Qualitest for $1.2 Billion originally appeared on DailyFinance on Tue, 28 Sep 2010 06:31:00.
Filed Under: Company News, Health Care, Retail
A proposed Hodgkin’s lymphoma treatment returned positive test results in a clinical trial, according to drugmaker Seattle Genetics Inc., which seeks to file the drug for approval with the U.S. Food and Drug Administration next…